Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL PK and Safety in Spinal Fusion Surgery
NCT02985762Phase 1Completed
- Sponsor
- Pacira BioSciences
- Start
- Dec 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of liposomal bupivacaine in Persistent postsurgical pain (PPSP), sponsored by Pacira BioSciences. Primary endpoints: Area under the plasma concentration-versus-time curve from time of administration extrapolated to infinity at 7 days, Visual Analog Scale pain intensity scores at 72 hours and 12 more. Started Dec 2016; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02985762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985762.